Abstract:The serine-threonine kinase, tumor progression locus 2 (Tpl2, also known as Map3k8/Cot), is a potent inflammatory mediator that drives the production of TNFα, IL-1β, and IFNγ. We previously demonstrated that Tpl2 regulates TCR signaling and modulates T helper cell differentiation. However, very little is known about how Tpl2 modulates the development of regulatory T cells (Tregs). Tregs are a specialized subset of T cells that express FoxP3 and possess immunosuppressive properties to limit excess inflammation. Because of the documented role of Tpl2 in promoting inflammation, we hypothesized that Tpl2 antagonizes Treg development and immunosuppressive function. Herein, we demonstrate that Tpl2 constrains the development of inducible Tregs (iTregs). Tpl2 naïve CD4 T cells preferentially develop into FoxP3 iTregs in vitro as well as in vivo in a murine model of OVAinduced systemic tolerance. Treg biasing of Tpl2 T cells depended upon the TCR signal strength and corresponded with reduced activation of the mammalian target of rapamycin (mTOR) pathway. Importantly, Tpl2 Tregs have basally increased expression of FoxP3 and immunosuppressive molecules, IL-10 and cytotoxic T lymphocyteassociated protein 4 (CTLA-4). Furthermore, they were more immunosuppressive in vivo in a T cell transfer model of colitis, as evidenced by reducing effector T cell accumulation, systemic production of inflammatory cytokines, and colonic inflammation. These results demonstrate that Tpl2 promotes inflammation in part by constraining FoxP3 expression and Treg immunosuppressive functions. Overall these findings suggest that Tpl2 inhibition could be used to preferentially drive Treg induction and thereby limit inflammation in a variety of autoimmune diseases. INTRODUCTION Pathogenesis of a number of autoimmune diseases is attributed to self-reactive T cells that recognize self-antigens and trigger organ-specific damage (1). Regulatory T cells are a specialized lineage of T cells with immunosuppressive properties. The forkhead box P3 (FoxP3) transcription factor is important in specifying this lineage (2,3), and humans with mutations in the Foxp3 gene develop severe multi-organ autoimmune disease including autoimmune enteropathy, dermatitis, thyroiditis, and type I diabetes (4). This syndrome is highly homologous to that observed in scurfy mice that also harbor mutations within the Foxp3 gene (5). Tregs arise naturally in the thymus (natural Tregs, nTregs or thymus-derived Tregs, tTregs) or can be induced from naïve conventional T cells in the periphery (inducible Tregs; iTregs) (6-9). Both types of FoxP3 Tregs exhibit critical immunoregulatory functions to maintain central and peripheral http://www.jbc.org/cgi/doi/10.1074/jbc.M116.718783 The latest version is at JBC Papers in Press. Published on June 3, 2016 as Manuscript M116.718783 Copyright 2016 by The American Society for Biochemistry and Molecular Biology, Inc. by gest on N ovem er 8, 2017 hp://w w w .jb.org/ D ow nladed from

Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal Phosphorylation

Neuropilin-1 Identifies a New Subpopulation of TGF--Induced Foxp3<SUP>+</SUP> Regulatory T Cells With Potent Suppressive Function and Enhanced Stability During Inflammation

PIM1 Kinase Phosphorylates the Human Transcription Factor FOXP3 at Serine 422 to Negatively Regulate Its Activity under Inflammation*

Nemo-like Kinase Drives Foxp3 Stability and is Critical for Maintenance of Immune Tolerance by Regulatory T Cells.

T Cell Signaling Targets for Enhancing Regulatory or Effector Function.

Pim-1 Kinase Regulates CD4+T Cell Differentiation

PIM kinase control of CD8 T cell protein synthesis and cell trafficking

Foxp3 Post-translational Modifications and Treg Suppressive Activity

PARP-1 Controls Immunosuppressive Function of Regulatory T Cells by Destabilizing Foxp3

Distinct palmitoylation of Foxp3 regulates the function of regulatory T cells via palmitoyltransferases

Tumor progression locus 2 ( Tpl 2 ) activates the mTOR pathway , inhibits FoxP 3 expression and limits Treg immunosuppressive functions

Pim2 Negatively Regulates T-cell Immune Responses Through Modulating Autophagy

PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity.

Targeting Pim2 for Improving T-Cell Effector Function and Promoting Cancer Immunotherapy

Dynamic Foxp3-chromatin Interaction Controls Tunable Treg Cell Function.

Protein phosphatase 6 (Pp6) is crucial for regulatory T cell function and stability in autoimmunity

Novel Foxo1-dependent Transcriptional Programs Control Treg Cell Function

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

Foxp1 is Critical for the Maintenance of Regulatory T-cell Homeostasis and Suppressive Function.

Cimetidine Down-Regulates Stability of Foxp3 Protein Via Stub1 in Treg Cells

Mammalian Sterile 20-like Kinase 1 (Mst1) Enhances the Stability of Forkhead Box P3 (Foxp3) and the Function of Regulatory T Cells by Modulating Foxp3 Acetylation.